Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Esophageal Neoplasms × Azacitidine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 86 Myelodysplastic Syndromes 50 Leukemia, Myelomonocytic, Chronic 19 Leukemia 14 Lymphoma, Non-Hodgkin 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Hodgkin Disease 8 Hematologic Neoplasms 8 Recurrence 7 Multiple Myeloma 7 Neoplasms 6 Myeloproliferative Disorders 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Carcinoma, Non-Small-Cell Lung 6 Lymphoma 5 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Sarcoma 4 Primary Myelofibrosis 4 Ovarian Neoplasms 4 Myelodysplastic-Myeloproliferative Diseases 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, Follicular 4 Leukemia, Myeloid 4 Leukemia, Biphenotypic, Acute 4 Anemia, Refractory, with Excess of Blasts 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasm Metastasis 3 Melanoma 3 Lymphoma, T-Cell, Peripheral 3 Lymphoma, T-Cell, Cutaneous 3

Interventions

Paclitaxel 16 Fluorouracil 15 Cisplatin 15 Carboplatin 15 pembrolizumab 14 Irinotecan 11 Radiotherapy 10 Oxaliplatin 10 Cyclophosphamide 10 Capecitabine 9 Leucovorin 8 Radiation 7 Docetaxel 7 fludarabine 6 Gemcitabine 6 Trastuzumab 5 Taxes 5 fludarabine phosphate 4 LY6K protein, human 4 Fluorodeoxyglucose F18 4 Erlotinib Hydrochloride 4 Bevacizumab 4 spartalizumab 3 aldesleukin 3 Surgical Procedures, Operative 3 S 1 (combination) 3 Pemetrexed 3 Nivolumab 3 Drug Therapy 3 zimberelimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01386346 2018-12-12

VEOX

Weill Medical College of Cornell University

Phase 1 Completed

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡